INDEPENDENT FINANCIAL GROUP, LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 275484
SAN DIEGO, CA
Position in ARWR
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,174,559
+$210,547 QoQ
Shares Held
14,410
-6.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#5
of 26 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INDEPENDENT FINANCIAL GROUP, LLC holds $5,426,584 across 14 Biotechnology names. ARWR ranks #1 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
14,410 | $1,174,559 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,089 | $679,035 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,345 | $668,101 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
5,857 | $458,427 | |
| 5 | CTNM |
Contineum Therapeutics, Inc.
|
27,021 | $442,874 | |
| 6 | EXEL |
Exelixis, Inc.
|
6,871 | $373,851 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
23,250 | $343,170 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
6,062 | $330,621 |
All Filings in ARWR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,174,559 | 14,410 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $964,012 | 15,375 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,065,559 | 16,050 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $583,743 | 16,925 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $536,963 | 33,985 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $506,835 | 39,783 | Shares | Sole | 2026-05-19 | |
| 2024-12-31 | $718,254 | 38,205 | Shares | Sole | 2026-06-12 | |
| 2024-09-30 | $426,236 | 22,005 | Shares | Sole | 2026-06-12 | |
| 2024-06-30 | $284,590 | 10,950 | Shares | Sole | 2026-06-12 | |
| 2024-03-31 | $238,810 | 8,350 | Shares | Sole | 2026-06-12 | |
| 2023-12-31 | $276,165 | 9,025 | Shares | Sole | 2026-06-12 | |
| 2023-09-30 | $201,525 | 7,500 | Shares | Sole | 2026-06-12 | |
| 2023-06-30 | $260,318 | 7,300 | Shares | Sole | 2026-06-12 | |
| 2022-12-31 | $241,332 | 5,950 | Shares | Sole | 2026-06-15 | |
| 2022-09-30 | $215,651 | 6,525 | Shares | Sole | 2026-06-15 | |
| 2022-06-30 | $240,308 | 6,825 | Shares | Sole | 2026-06-12 | |
| 2022-03-31 | $272,490 | 5,925 | Shares | Sole | 2026-06-12 | |
| 2021-12-31 | $353,047 | 5,325 | Shares | Sole | 2026-06-15 | |
| 2021-09-30 | $294,981 | 4,725 | Shares | Sole | 2026-06-15 | |
| 2021-06-30 | $258,481 | 3,121 | Shares | Sole | 2026-06-15 | |
| No filing history on record for this holder in this stock. | ||||||